General Anesthesia — MCQs

General Anesthesia Indian Medical PG Practice Questions and MCQs

Question 351: What are the known effects of halothane?

A. Bradycardia
B. Fall in blood pressure
C. Uterine relaxation
D. All of the above (Correct Answer)

Explanation: **Explanation:** Halothane is a potent volatile anesthetic agent with several distinct physiological effects that are frequently tested in NEET-PG. The correct answer is **"All of the above"** because halothane acts as a systemic depressant across multiple organ systems. 1. **Bradycardia:** Halothane increases vagal tone and has a direct depressant effect on the sinoatrial (SA) node. Furthermore, it sensitizes the myocardium to circulating catecholamines (arrhythmogenic potential), which can lead to ventricular arrhythmias, especially if exogenous adrenaline is used. 2. **Fall in Blood Pressure:** Halothane causes a dose-dependent decrease in arterial blood pressure. This is primarily due to **direct myocardial depression** (negative inotropy) rather than peripheral vasodilation, leading to a reduction in cardiac output. 3. **Uterine Relaxation:** Halothane is a potent uterine relaxant. While this is useful for intrauterine manipulations (e.g., version), it is generally avoided during the third stage of labor or post-delivery because it can cause significant **postpartum hemorrhage (PPH)** by preventing uterine contraction. **Why other options are not "wrong" individually:** Options A, B, and C are all documented pharmacological effects of halothane. Therefore, selecting any single one would be incomplete, making "All of the above" the most accurate choice. **High-Yield Clinical Pearls for NEET-PG:** * **Halothane Hepatitis:** A rare but serious immune-mediated hepatotoxicity (more common in adults/obese patients). * **Malignant Hyperthermia:** Halothane is a known trigger (Treatment: Dantrolene). * **Sweet Smell:** It is non-pungent, making it the traditional agent of choice for smooth **inhalation induction** in pediatric patients (though largely replaced by Sevoflurane). * **Boiling Point:** 50.2°C; it requires a thymol preservative to prevent decomposition.

Question 352: Which of the following induction agents causes the least respiratory depression?

A. Midazolam
B. Ketamine (Correct Answer)
C. Propofol
D. Thiopentone

Explanation: **Explanation:** The correct answer is **Ketamine**. Unlike most induction agents that act as central nervous system depressants, Ketamine is a **dissociative anesthetic** that acts primarily as an NMDA receptor antagonist. **Why Ketamine is correct:** Ketamine is unique because it **preserves the upper airway muscle tone** and maintains **protective airway reflexes** (cough and swallow). Most importantly, it does not cause significant respiratory depression; instead, it may slightly increase the respiratory rate. It also acts as a potent **bronchodilator**, making it the induction agent of choice for patients with reactive airway diseases like asthma. **Why the other options are incorrect:** * **Propofol:** Known for causing significant dose-dependent respiratory depression and **apnea** (occurring in 25-35% of patients). It also reduces the ventilatory response to hypoxia and hypercapnia. * **Thiopentone:** A barbiturate that causes potent dose-dependent depression of the medullary respiratory centers, leading to a decrease in tidal volume and respiratory rate. * **Midazolam:** A benzodiazepine that causes mild to moderate respiratory depression, which can be synergistic and dangerous when combined with opioids. **High-Yield NEET-PG Pearls:** * **Ketamine** is the only induction agent that stimulates the sympathetic nervous system (increases HR, BP, and CO), making it ideal for **hypovolemic shock**. * **Contraindication:** Avoid Ketamine in patients with increased Intracranial Pressure (ICP) or Intraocular Pressure (IOP). * **Side Effect:** Watch for **emergence delirium** (vivid dreams/hallucinations), which can be mitigated by pre-treating with Midazolam. * **Drug of Choice:** Ketamine is the preferred agent for **pediatric procedures** and **burn dressing changes**.

Question 353: Which of the following volatile anesthetics has the least fluoride content?

A. Enflurane
B. Isoflurane
C. Sevoflurane
D. Desflurane (Correct Answer)

Explanation: ### Explanation The correct answer is **Desflurane**. The fluoride content of volatile anesthetics is determined by the number of fluorine atoms in their chemical structure. This is clinically significant because the metabolic breakdown of these agents can release inorganic fluoride ions ($F^-$), which are potentially nephrotoxic. **1. Why Desflurane is Correct:** Desflurane is a fluorinated methyl ethyl ether. While it contains **six fluorine atoms** in its molecule, it is extremely stable due to its structure. It undergoes minimal hepatic metabolism (only **0.02%**), resulting in the **least release of inorganic fluoride** among all the options. This makes it virtually non-toxic to the kidneys. **2. Analysis of Incorrect Options:** * **Enflurane:** It contains five fluorine atoms but undergoes significant metabolism (~2.5%). It releases the highest amount of fluoride among the older agents, posing a risk of "high-output renal failure." * **Isoflurane:** An isomer of enflurane with five fluorine atoms. It is very stable with low metabolism (~0.2%), but its fluoride release is still higher than that of desflurane. * **Sevoflurane:** It contains **seven fluorine atoms** (the highest number). It undergoes the most significant metabolism (~5–8%) among modern agents, leading to higher serum fluoride levels. However, it is not typically nephrotoxic in humans unless it reacts with soda lime to form **Compound A**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Metabolism Rank (Highest to Lowest):** Methoxyflurane (50%) > Halothane (20%) > Sevoflurane (5-8%) > Enflurane (2.5%) > Isoflurane (0.2%) > Desflurane (0.02%). * **Nephrotoxicity:** Methoxyflurane is the most nephrotoxic (now obsolete). Sevoflurane is associated with **Compound A** formation in CO2 absorbers. * **Boiling Point:** Desflurane has the lowest boiling point (23.5°C), requiring a special heated vaporizer (Tec 6). * **Blood-Gas Partition Coefficient:** Desflurane (0.42) is the least soluble, leading to the fastest induction and recovery.

Question 354: Hallucinations are commonly seen with which of the following agents?

A. Ketamine (Correct Answer)
B. Halothane
C. Ether
D. Cyclopropane

Explanation: **Explanation:** **Ketamine** is the correct answer because it is a phencyclidine derivative that acts as a non-competitive NMDA receptor antagonist. It induces a unique state known as **Dissociative Anesthesia**, where the patient appears awake but is detached from their surroundings. During the recovery phase, approximately 10–30% of adults experience **Emergence Reactions**, which include vivid dreams, illusions, and **hallucinations**. These occur because ketamine depresses the thalamoneocortical system while stimulating parts of the limbic system. **Analysis of Incorrect Options:** * **Halothane:** A volatile anesthetic known for causing cardiac arrhythmias (sensitizes myocardium to catecholamines) and "Halothane Hepatitis," but it does not typically cause hallucinations. * **Ether:** An irritating, flammable agent historically used for its analgesic properties. Its primary side effects are prolonged induction, postoperative nausea/vomiting (PONV), and respiratory secretions, not hallucinations. * **Cyclopropane:** An obsolete explosive gas known for causing "Cyclopropane shock" (hypotension post-op) and arrhythmias. It does not have a significant association with hallucinogenic emergence. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** Emergence hallucinations can be minimized by pre-medicating with **Benzodiazepines** (e.g., Midazolam). * **Hemodynamics:** Ketamine is the drug of choice for **induction in shock/hypovolemia** because it increases BP, HR, and CO via sympathetic stimulation. * **Respiratory:** It is the agent of choice for **Asthmatics** due to its potent bronchodilatory properties. * **Contraindication:** Avoid in patients with head injuries as it **increases Intracranial Pressure (ICP)** and Intraocular Pressure (IOP).

Question 355: Which route provides the fastest reversible anesthesia?

A. Inhalational (Correct Answer)
B. Intravenous (IV)
C. Local anesthesia
D. None of the above

Explanation: **Explanation:** The correct answer is **Inhalational (Option A)**. The primary reason for this is the unique pharmacokinetic profile of inhalational agents, specifically their ability to be eliminated via the lungs. **Why Inhalational is Correct:** Inhalational anesthesia allows for the fastest **reversibility** because these agents are excreted primarily through exhalation. Once the vaporizer is turned off and the patient is ventilated with 100% oxygen, the concentration gradient reverses, drawing the anesthetic out of the blood and brain back into the lungs for elimination. This process is rapid and does not depend on hepatic metabolism or renal excretion, which are significantly slower processes. **Why Other Options are Incorrect:** * **Intravenous (IV):** While IV agents (like Propofol) have a very fast *onset*, their reversal depends on redistribution to peripheral tissues and subsequent metabolism by the liver. Once injected, they cannot be physically "removed" from the body as easily as a gas. * **Local Anesthesia:** These agents work by blocking sodium channels at a specific site. Reversal depends entirely on the rate of systemic absorption and metabolic breakdown (by plasma esterases or liver enzymes), making it much slower than the breath-by-breath elimination of gases. **NEET-PG High-Yield Pearls:** * **Blood-Gas Partition Coefficient:** This determines the speed of induction and recovery. The **lower** the coefficient (e.g., Desflurane = 0.42), the faster the recovery/reversibility. * **Desflurane** provides the fastest recovery among all inhalational agents. * **Context-Sensitive Half-Time:** This concept explains why IV infusions (like Fentanyl) take longer to reverse the longer they are administered, a phenomenon less pronounced with modern inhalational agents.

Question 356: Which one of the following is the shortest acting intravenous analgesic?

A. Remifentanil (Correct Answer)
B. Fentanyl
C. Alfentanil
D. Sufentanil

Explanation: **Explanation:** The correct answer is **Remifentanil**. The primary medical concept determining its duration of action is its unique metabolism. **Why Remifentanil is correct:** Remifentanil is an ultra-short-acting μ-opioid agonist. Unlike other opioids metabolized by the liver, Remifentanil contains an **ester linkage** that makes it susceptible to rapid hydrolysis by **nonspecific plasma and tissue esterases**. This results in an extremely short context-sensitive half-life (approximately 3–4 minutes) that remains constant regardless of the duration of infusion. This makes it ideal for procedures requiring intense analgesia with rapid recovery. **Why other options are incorrect:** * **Fentanyl:** It is a potent phenylpiperidine derivative but has a longer duration of action due to its high lipid solubility and tendency to redistribute into peripheral tissues. Its context-sensitive half-life increases significantly with prolonged infusion. * **Alfentanil:** While it has a faster onset than Fentanyl due to its low pKa (mostly unionized at physiological pH), its metabolism is hepatic (CYP3A4). It is longer-acting than Remifentanil. * **Sufentanil:** This is the most potent opioid (5–10 times more potent than Fentanyl) but has a longer elimination half-life and duration of action compared to Remifentanil. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Remifentanil metabolism is independent of renal or hepatic function (safe in organ failure). * **Context-Sensitive Half-life:** This is the time required for the plasma concentration to decrease by 50% after stopping an infusion. Remifentanil has the shortest and most stable context-sensitive half-life among all opioids. * **Potency Order:** Sufentanil > Remifentanil ≈ Fentanyl > Alfentanil > Morphine. * **Side Effect:** Rapid administration can cause significant **chest wall rigidity** (wooden chest syndrome).

Question 357: Which anesthetic agent is known to cause muscle rigidity?

A. Halothane
B. Ether
C. Sevoflurane
D. Alfentanil (Correct Answer)

Explanation: **Explanation:** **Correct Option: D. Alfentanil** The correct answer is **Alfentanil**. Muscle rigidity, specifically "Chest Wall Rigidity" (or "Wooden Chest Syndrome"), is a well-known side effect of **potent opioids**, particularly the phenylpiperidine derivatives like Fentanyl, Sufentanil, Alfentanil, and Remifentanil. * **Mechanism:** This rigidity is mediated via **mu-opioid receptors** in the central nervous system (specifically the striatum and substantia nigra). It involves a decrease in GABAergic inhibition and an increase in dopaminergic and glutamatergic outflow, leading to intense contraction of the laryngeal and skeletal muscles (especially the chest wall and abdomen), which can make bag-mask ventilation extremely difficult. **Incorrect Options:** * **A, B, and C (Halothane, Ether, Sevoflurane):** These are volatile/inhalational anesthetics. Unlike opioids, inhalational agents typically cause **muscle relaxation** (dose-dependent) and potentiate the action of neuromuscular blocking agents. While Halothane and Sevoflurane are triggers for Malignant Hyperthermia (which involves muscle rigidity), they do not cause primary muscle rigidity as a direct pharmacological effect during induction. **High-Yield Clinical Pearls for NEET-PG:** * **Management:** The drug of choice to reverse opioid-induced chest wall rigidity is a rapid-acting neuromuscular blocking agent like **Succinylcholine**. Naloxone can also reverse it but will also abolish analgesia. * **Speed of Administration:** Rigidity is most common when high doses of opioids are administered **rapidly** during induction. * **Alfentanil** has the fastest onset and shortest peak effect time among the fentanyl congeners, making it frequently associated with this phenomenon during rapid bolus administration.

Question 358: Laudanosine is a metabolite of which neuromuscular blocking agent?

A. Atracurium (Correct Answer)
B. Cisatracurium
C. Pancuronium
D. Vecuronium

Explanation: **Explanation:** **Atracurium** is a benzylisoquinolinium neuromuscular blocking agent (NMBA) that undergoes unique metabolism via **Hofmann elimination** (a non-enzymatic degradation occurring at physiological pH and temperature) and ester hydrolysis. **Laudanosine** is the major tertiary amine metabolite produced during this process. * **Why Option A is correct:** Atracurium produces significant amounts of laudanosine. Because laudanosine is metabolized by the liver and excreted in urine, its levels can rise during prolonged infusions. * **Why Option B is incorrect:** While **Cisatracurium** (the R-cis isomer of atracurium) also produces laudanosine via Hofmann elimination, it is 3–4 times more potent than atracurium. Therefore, much smaller doses are required, resulting in **significantly lower (negligible) levels** of laudanosine compared to atracurium. * **Why Options C & D are incorrect:** **Pancuronium** and **Vecuronium** are aminosteroid NMBAs. They are primarily metabolized by the liver and excreted by the kidneys; they do not undergo Hofmann elimination and do not produce laudanosine. **Clinical Pearls for NEET-PG:** 1. **CNS Toxicity:** Laudanosine is a known **CNS stimulant**. In high concentrations (rare in clinical practice but possible with prolonged infusions in ICU patients), it can cross the blood-brain barrier and potentially cause **seizures**. 2. **Organ Independence:** Both Atracurium and Cisatracurium are the drugs of choice in patients with **renal or hepatic failure** due to Hofmann elimination. 3. **Histamine Release:** Atracurium is associated with histamine release (causing flushing/hypotension), whereas Cisatracurium does not cause significant histamine release.

Question 359: What constitutes the triad of general anesthesia?

A. Narcosis, analgesia, and relaxation
B. Analgesia, amnesia, and relaxation (Correct Answer)
C. Unconsciousness, amnesia, and loss of reflex
D. Loss of reflex, narcosis, and analgesia

Explanation: The concept of the **Triad of General Anesthesia** (originally proposed by Gray and Rees) defines the three essential components required to provide optimal surgical conditions while ensuring patient safety and comfort. ### 1. Why Option B is Correct The modern triad consists of: * **Analgesia:** Insensitivity to pain, ensuring the patient does not perceive surgical stimuli. * **Amnesia:** Loss of memory of the perioperative events (often achieved through unconsciousness/hypnosis). * **Muscle Relaxation:** Paralysis of skeletal muscles to facilitate endotracheal intubation and provide a quiet surgical field (especially for abdominal surgeries). By using a combination of drugs to achieve these three goals separately (Balanced Anesthesia), we can minimize the dose of any single agent, thereby reducing toxicity and side effects. ### 2. Analysis of Incorrect Options * **Options A & D:** These include **Narcosis**, which is an older term referring to a state of stupor or drowsiness. While narcosis is a part of the anesthetic state, "Amnesia" is the more precise clinical requirement for modern general anesthesia. * **Option C:** While **Unconsciousness** and **Loss of Reflexes** occur during anesthesia, they are considered subsets or consequences of the primary triad. Loss of reflex is often a sign of anesthetic depth rather than a primary goal itself. ### 3. NEET-PG High-Yield Pearls * **Balanced Anesthesia:** This term refers to using a combination of intravenous drugs (e.g., Propofol), inhalational agents (e.g., Sevoflurane), and neuromuscular blockers (e.g., Vecuronium) to achieve the triad safely. * **The "Fourth" Element:** Some modern texts include a fourth component: **Areflexia** (suppression of autonomic reflexes), making it a "Tetrad." * **Ideal Agent:** No single anesthetic agent perfectly provides all three components of the triad without significant side effects, which is why multi-drug regimens are the gold standard.

Question 360: What is true about Nitrous Oxide (N2O)?

A. It is a good muscle relaxant.
B. It has low potency and provides good analgesia. (Correct Answer)
C. It has high potency and poor analgesia.
D. None of the above.

Explanation: ### Explanation **Nitrous Oxide ($N_2O$)** is a colorless, odorless gas widely used in anesthesia. The correct answer is **Option B** because of its unique pharmacological profile: 1. **Low Potency:** Potency of an inhalational agent is measured by its **MAC (Minimum Alveolar Concentration)**. $N_2O$ has a MAC of approximately **104%**, making it the least potent inhalational agent. Since it cannot achieve surgical anesthesia at 1 atmospheric pressure without causing hypoxia, it is never used as a sole anesthetic agent. 2. **Good Analgesia:** Despite its low anesthetic potency, $N_2O$ is an excellent analgesic. It is often used in concentrations of 30-50% for "conscious sedation" in dentistry and labor (Entonox). #### Why other options are incorrect: * **Option A:** $N_2O$ has **no muscle relaxant properties**. In fact, at high concentrations, it may cause skeletal muscle rigidity. * **Option C:** This is the inverse of the truth. $N_2O$ is characterized by **low potency** (high MAC) and **strong analgesia**. #### High-Yield Clinical Pearls for NEET-PG: * **Blood-Gas Partition Coefficient:** It is **0.47** (very low), leading to rapid induction and rapid recovery. * **Second Gas Effect:** $N_2O$ is absorbed rapidly from the alveoli into the blood, concentrating the co-administered "second gas" (e.g., Halothane), thereby increasing its uptake. * **Diffusion Hypoxia (Fink Effect):** Post-operatively, $N_2O$ rushes out of the blood into the alveoli, diluting oxygen. This is prevented by giving **100% $O_2$ for 5-10 minutes** after stopping $N_2O$. * **Contraindications:** Because it is 30 times more soluble than Nitrogen, it expands closed gas spaces. It is contraindicated in **Pneumothorax, Bowel obstruction, Air embolism, and Middle ear surgeries (Tympanoplasty).** * **Toxicity:** Long-term exposure inhibits **Vitamin $B_{12}$ dependent enzyme methionine synthase**, leading to megaloblastic anemia and peripheral neuropathy.

Practice by Chapter

History of Anesthesia

Practice Questions

Preoperative Evaluation

Practice Questions

Pharmacology of Inhalational Anesthetics

Practice Questions

Pharmacology of Intravenous Anesthetics

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Airway Management

Practice Questions

Endotracheal Intubation

Practice Questions

Difficult Airway Algorithms

Practice Questions

Intraoperative Monitoring

Practice Questions

Depth of Anesthesia Monitoring

Practice Questions

Emergence from Anesthesia

Practice Questions

Postoperative Care

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free